NEW YORK, NY, Bluespine, an AI-driven claims cost reduction platform for self-insured employers, today announced it has raised $7.2 million in a seed funding round.
The round was led by Team8, with participation from strategic partners, to tackle medical overbilling, which is a symptom of the $300 billion fraud, waste, and abuse (FWA) healthcare crisis. With employer healthcare expenses up 14% over the past two years, Bluespine's innovative solution helps plan sponsors to lower costs without compromising care, protecting employers from financial leakage and helping them meet their fiduciary obligations.
Bluespine is an AI-driven claims cost reduction solution that empowers self-insured employers to lower annual healthcare spending while mitigating financial and legal risks around plan administration. Founded in 2023 by a team of seasoned technology and cybersecurity experts, Bluespine's mission is to reduce wasteful healthcare spending and empower companies to better serve their employees' health needs. Headquartered in Manhattan and backed by industry leaders, Bluespine serves Fortune 500 companies and other large self-insured employers, healthcare brokers, and auditors.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.